Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZIRGAN | Bausch Health Companies | N-022211 RX | 2009-09-15 | 1 products, RLD, RS |
GANZYK-RTU | Exela Pharma Sciences | N-209347 RX | 2017-02-17 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CYTOVENE | CHEPLAPHARM Arzneimittel | N-019661 DISCN | 1989-06-23 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
ganciclovir | ANDA | 2021-08-31 |
zirgan | New Drug Application | 2019-09-03 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
aids-related opportunistic infections | — | D017088 | — |
cytomegalovirus infections | EFO_0001062 | D003586 | B25 |
cytomegalovirus retinitis | EFO_1001302 | D017726 | — |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Ganciclovir, Ganzyk-Rtu, Exela Pharma | |||
9486530 | 2034-09-02 | DP |
Code | Description |
---|---|
J1570 | Injection, ganciclovir sodium, 500 mg |
J1574 | Injection, ganciclovir sodium (exela) not therapeutically equivalent to j1570, 500 mg |
J7310 | Ganciclovir, 4.5 mg, long-acting implant |
Level 3: J7310-J7310 | Ganciclovir |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 10 | 6 | 9 | 1 | 19 | 45 |
Cytomegalovirus infections | D003586 | EFO_0001062 | B25 | 5 | 4 | 9 | 8 | 14 | 38 |
Cytomegalovirus retinitis | D017726 | EFO_1001302 | — | 7 | 6 | 8 | 1 | 14 | 36 |
Infections | D007239 | EFO_0000544 | — | — | — | 1 | 1 | — | 2 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | — | — | — | 1 | — | 1 |
Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | — | — | 1 | — | 1 |
Keratoconjunctivitis | D007637 | — | H16.2 | — | — | — | 1 | — | 1 |
Virus shedding | D017201 | — | — | — | — | — | 1 | — | 1 |
Viremia | D014766 | — | B34.9 | — | — | — | 1 | — | 1 |
Herpesviridae infections | D006566 | EFO_0007309 | B00.4 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenoviridae | D000256 | — | — | — | 1 | 1 | — | — | 2 |
Respiratory insufficiency | D012131 | HP_0002093 | J96.9 | — | 1 | 1 | — | — | 2 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | — | 2 | — | — | 2 |
Conjunctivitis | D003231 | HP_0000509 | H10 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 2 | 3 | — | — | 1 | 6 |
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | 1 | 2 | — | — | — | 3 |
Leukemia | D007938 | — | C95 | 1 | 1 | — | — | 1 | 3 |
Human herpesvirus 8 | D019288 | — | — | — | 2 | — | — | — | 2 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | 2 | 1 | — | — | — | 2 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | 1 | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Hiv | D006678 | — | O98.7 | — | 1 | — | — | — | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver transplantation | D016031 | EFO_0010682 | — | 1 | — | — | — | 1 | 2 |
Melanoma | D008545 | — | — | 2 | — | — | — | — | 2 |
Colitis | D003092 | EFO_0003872 | K52.9 | 1 | — | — | — | 1 | 2 |
Nasopharyngeal carcinoma | D000077274 | — | — | 1 | — | — | — | — | 1 |
Nasopharyngeal neoplasms | D009303 | — | — | 1 | — | — | — | — | 1 |
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | — | — | — | — | 1 |
Precancerous conditions | D011230 | — | — | 1 | — | — | — | — | 1 |
Malignant mesothelioma | D000086002 | — | — | 1 | — | — | — | — | 1 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anterior uveitis | D014606 | EFO_1000811 | — | — | — | — | — | 2 | 2 |
Myelodysplastic syndromes | D009190 | — | D46 | — | — | — | — | 2 | 2 |
Cerebral hemorrhage | D002543 | — | — | — | — | — | — | 1 | 1 |
Subarachnoid hemorrhage | D013345 | EFO_0000713 | I60 | — | — | — | — | 1 | 1 |
Drug monitoring | D016903 | — | — | — | — | — | — | 1 | 1 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 1 | 1 |
Viral drug resistance | D024882 | — | — | — | — | — | — | 1 | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 1 | 1 |
Graves disease | D006111 | EFO_0004237 | E05.0 | — | — | — | — | 1 | 1 |
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | — | 1 | 1 |
Drug common name | Ganciclovir |
INN | ganciclovir |
Description | Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections.
|
Classification | Small molecule |
Drug class | antivirals: antivirals (acyclovir type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1 |
PDB | — |
CAS-ID | 82410-32-0 |
RxCUI | — |
ChEMBL ID | CHEMBL182 |
ChEBI ID | 465284 |
PubChem CID | 3454 |
DrugBank | DB01004 |
UNII ID | P9G3CKZ4P5 (ChemIDplus, GSRS) |